More Singular Health Group Ltd news
Singular Health Group LtdASX: SHG

US FDA 510(k) clearance for 3Dicom MD

Oct 26, 2022 at 10:31 PM EDT · Issued by Singular Health Group Ltd

Filed with ASX · Oct 26, 2022 at 10:31 PM EDT

On 6ix: 6ix.com/news/us-fda-510k-clearance-for-3dicom-md

Singular Health Group Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Singular Health Group Ltd on 6ix

Story so far

  • 3D Medical Software Launch and FDA 510(K) ApplicationApr 28, 2021

Earlier from Singular Health

  • SHG signs Research Agreement with AOWA and ECUAug 31, 2022
  • SHG Secures Convertible Note InvestmentAug 10, 2022
  • Singular Health Announces Planned Divestment of GeoVR AssetAug 7, 2022
  • AE Commissions Medical Manufacturing FacilityMar 15, 2022
  • SHG: & CSIRO AI Tool to Optimise Cranial Implant ProceduresMar 13, 2022

Later from Singular Health

  • Singular Appoints US-Agent & 3Dicom Partner Program MemberNov 8, 2022
  • Acquisition Global3D business and Share Purchase PlanDec 5, 2022
  • Investor PresentationDec 5, 2022
  • Share Purchase Plan - Offer DocumentDec 5, 2022
  • Half Year AccountsFeb 24, 2023
All Singular Health news releases↗

Follow Singular Health into a list and get an email when it puts out news.

Follow Singular Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer